Compare CDZI & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDZI | ORGO |
|---|---|---|
| Founded | 1983 | 1985 |
| Country | United States | United States |
| Employees | 25 | N/A |
| Industry | Water Supply | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 410.6M | 348.6M |
| IPO Year | N/A | 2016 |
| Metric | CDZI | ORGO |
|---|---|---|
| Price | $4.87 | $2.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 467.6K | ★ 659.4K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | $64.02 | N/A |
| Revenue Next Year | $28.16 | $26.27 |
| P/E Ratio | ★ N/A | $15.27 |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $2.13 | $2.28 |
| 52 Week High | $6.96 | $7.08 |
| Indicator | CDZI | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 42.34 | 22.28 |
| Support Level | $4.46 | N/A |
| Resistance Level | $5.75 | $4.12 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 36.65 | 7.14 |
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.